DCF — MERCY MEDICAL CENTER
Enterprise Value: $-362.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-362.1M
Enterprise Value
$-126.4M
PV of Cash Flows
$-235.7M
PV of Terminal Value
$-379.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $578.1M | $-16.1M | -3.0% | $-40.6M | $-36.9M |
| Year 2 | $595.5M | $-10.6M | -2.0% | $-35.8M | $-29.6M |
| Year 3 | $613.4M | $-4.8M | -1.0% | $-30.8M | $-23.1M |
| Year 4 | $631.8M | $-1.8M | -0.0% | $-28.5M | $-19.5M |
| Year 5 | $650.7M | $-0.2M | -0.0% | $-27.8M | $-17.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-362.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$561.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.032860045420426594
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5